In the so-called ‘three-hit’ animal model of schizophrenia, CB1r binding and cannabinoid agonist-mediated G-protein activation decreased in cortical, subcortical, and cerebellar brain regions [326]. The gene discussed is CNR1; the disease is schizophrenia.